DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia

European Journal of Pharmacology

Volumn 370, Issue 2, 1999, Pages 117-123

  Sato, Toshiyuki ^a   Morishima, Yoshiyuki ^a   Sugimura, Masunobu ^a   Uchida, Toshihiro ^a   Shirasaki, Yasufumi ^a  

^a New Prod Research Laboratories III   (Japan)

Author keywords

Calmodulin antagonist; Cerebral infarction; DY 9760e; Fodrin; Ischemia, transient, focal

Indexed keywords

CALMODULIN INHIBITOR; DY 9760E; FODRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; CALMODULIN; CARRIER PROTEINS; CEREBRAL ARTERIES; CEREBRAL CORTEX; CONSTRICTION, PATHOLOGIC; CORPUS STRIATUM; INDAZOLES; INFUSIONS, INTRAVENOUS; MALE; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR;

EID: 0032966871     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00133-8     Document Type: Article

References (33)

1. Astrup J., Siesjo B.K., Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 12:1981;723-725.
2. Bartus R.T., Dean R.L., Cavanaugh K., Eveleth D., Carriero D.L., Lynch G. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15:1995;969-979.
3. Belayev L., Busto R., Zhao W., Ginsberg M.D. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke. 26:1995;2313-2320.
4. Buisson A., Margaill I., Callebert J., Plotkine M., Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61:1993;690-696.
5. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
6. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal cell death. Trends Neurosci. 18:1995;58-60.
7. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;9808-9812.
8. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
9. Gill R., Sibson N.R., Hatfield R.H., Burdett N.G., Carpenter T.A., Hall L.D., Pickard J.D. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J. Cereb. Blood Flow Metab. 15:1995;1-11.
10. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., Wang K.K.W. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J. Neurosci. 15:1995;4093-4101.
11. Hoehn-Berlage M. Diffusion-weighted NMR imaging: application to experimental focal cerebral ischemia. NMR Biomed. 8:1995;345-358.
12. Ide T., Morikawa E., Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil. Neurosci. Lett. 204:1996;157-160.
13. James P., Vorherr T., Carafoli E. Calmodulin-binding domains: just two faced or multi-faceted? Trends Biochem. Sci. 20:1995;38-42.
14. Johnson G.V.W., Litersky J.M., Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56:1991;1630-1638.
15. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke. 8:1986;1-7.
16. Kuroda S., Nakai A., Kristian T., Siesjo B.K. The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats: anti-ischemic effect and therapeutic window. Stroke. 28:1997;2539-2544.
17. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
18. Memezawa H., Minamisawa H., Smith M.-L., Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 89:1992;67-78.
19. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 601:1993;103-110.
20. Nagafuji T., Matsui T., Koide T., Asano T. Blockade of nitric oxide formation by Nω-nitro-L-arginine mitigates ischemic brain edema and infarction in rats. Neurosci. Lett. 147:1992;159-162.
21. Picone C.M., Grotta J.C., Earls R., Strong R., Dedman J. Immunohistochemical determination of calcium-calmodulin binding predicts neuronal damage after global ischemia. J. Cereb. Blood Flow Metab. 9:1989;805-811.
22. Reith W., Hasegawa Y., Latour L.L., Dardzinski B.J., Sotak C.H., Fisher M. Multislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat stroke model. Neurology. 45:1995;172-177.
23. Roberts-Lewis J.M., Savage M.J., Marcy V.R., Pinsker L.R., Siman R. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14:1994;3934-3944.
24. Saido T.C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268:1993;25239-25243.
25. Seubert P., Baudry M., Dudek S., Lynch G. Calmodulin stimulates the degradation of brain spectrin by calpain. Synapse. 1:1987;20-24.
26. Sharkey J., Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 371:1994;336-339.
27. Sharkey J., Crawford J.H., Butcher S.P., Marston H.M. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke. 27:1996;2282-2286.
28. Siman R., Baudry M., Lynch G. Brain fodrin: Substrate for calpain I, an endogenous calcium-activated protease. Proc. Natl. Acad. Sci. USA. 81:1984;3572-3576.
29. Sugimura M., Sato T., Nakayama W., Morishima Y., Fukunaga K., Omitsu M., Miyamoto E., Shirasaki Y. DY-9760e, a novel calmodulin antagonist with cytoprotective action. Eur. J. Pharmacol. 336:1997;99-106.
30. Sun X., Shin C., Windebank A.J. Calmodulin in ischemic neurotoxicity of rat hippocampus in vitro. NeuroReport. 8:1997;415-418.
31. Takagaki Y., Itoh Y., Aoki Y., Ukai Y., Yoshikuni Y., Kimura K. Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: an implication for its neuroprotective action in rats with middle cerebral artery occlusion. J. Neurochem. 68:1997;2507-2513.
32. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
33. Zhou L.-W., Moyer J.A., Muth E.A., Clark B., Palkovits M., Weiss B. Regional distribution of calmodulin activity in rat brain. J. Neurochem. 44:1985;1657-1662.